- Report
- August 2026
- 110 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- August 2026
- 115 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- August 2026
- 142 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- August 2026
- 150 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 124 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 130 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 115 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 110 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 120 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 134 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- April 2026
- 70 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- April 2026
- 104 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- April 2026
- 120 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 185 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- July 2026
- 110 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- May 2026
- 400 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- September 2026
- 120 Pages
Global
From €7390EUR$7,990USD£6,167GBP
- Report
- July 2026
- 200 Pages
Global
From €7390EUR$7,990USD£6,167GBP
- Report
- July 2026
- 399 Pages
Global
From €7390EUR$7,990USD£6,167GBP
- Report
- January 2026
- 550 Pages
Global
From €4625EUR$5,000USD£3,859GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more